Dupuytren's disease can cause severe joint contracture in the hands, and surgery is often recommended for these patients most affected by the condition. But Dr. Lawrence Hurst, professor, chairman and chief of the division of hand surgery in the department of orthopaedics at Stony Brook School of Medicine Health Sciences Center, tells us about another new, non-surgical option that may soon be available for treating Dupuytren's contracture, using injectable collagenase. What types of patients are most susceptible to developing this condition? Dr. Lee Freedman hosts.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Treatment Approaches to Dupuytren's Contracture
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
Dupuytren's disease can cause severe joint contracture in the hands, and surgery is often recommended for these patients most affected by the condition. But Dr. Lawrence Hurst, professor, chairman and chief of the division of hand surgery in the department of orthopaedics at Stony Brook School of Medicine Health Sciences Center, tells us about another new, non-surgical option that may soon be available for treating Dupuytren's contracture, using injectable collagenase. What types of patients are most susceptible to developing this condition? Dr. Lee Freedman hosts.
Presenters
Facebook Comments